ResMed Inc. (RMD.AX)
AUD 36.93
(-2.51%)
AUD 36.93
(-2.51%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 4.68 Billion | 4.22 Billion | 3.19 Billion | 2.95 Billion | 2.6 Billion | 2.6 Billion |
| Cost of Revenue | 1.99 Billion | 1.86 Billion | 1.35 Billion | 1.23 Billion | 1.06 Billion | 1.11 Billion |
| Gross Profit | 2.68 Billion | 2.35 Billion | 1.83 Billion | 1.71 Billion | 1.53 Billion | 1.49 Billion |
| Operating Expenses | 1.37 Billion | 1.2 Billion | 926.74 Million | 908.72 Million | 900.59 Million | 858.08 Million |
| Selling, General and Administrative Expenses | 917.13 Million | 874 Million | 670.38 Million | 676.68 Million | 645.01 Million | 645.01 Million |
| Research and Development Expenses | 307.52 Million | 287.64 Million | 225.28 Million | 201.94 Million | 180.65 Million | 180.65 Million |
| Other Expenses | 110.74 Million | -5.71 Million | 14.81 Million | -12.15 Million | -10.72 Million | 2.56 Million |
| Cost and Expenses | 3.37 Billion | 3.07 Billion | 2.28 Billion | 2.14 Billion | 1.97 Billion | 1.97 Billion |
| Operating Income | 1.31 Billion | 1.13 Billion | 903.67 Million | 809.65 Million | 579.26 Million | 579.26 Million |
| Interest Expense | 45.7 Million | 47.37 Million | 23.98 Million | 40.37 Million | 36.15 Million | 36.15 Million |
| Income Tax Expense | 243.84 Million | 204.1 Million | 409.15 Million | 111.41 Million | 114.25 Million | 114.25 Million |
| Earnings before Tax | 1.26 Billion | 1.1 Billion | 883.66 Million | 733.08 Million | 518.84 Million | 518.84 Million |
| Net Income | 1.02 Billion | 897.55 Million | 474.5 Million | 474.5 Million | 404.59 Million | 404.59 Million |
| Earnings Per Share Basic | 6.92 | 0.61 | 0.32 | 0.43 | 0.28 | 0.28 |
| Earnings Per Share Diluted | 6.92 | 0.61 | 0.32 | 0.43 | 0.28 | 0.28 |
| Weighted Average Shares Outstanding | 147.53 Million | 1.46 Billion | 1.46 Billion | 1.45 Billion | 1.44 Billion | 1.43 Billion |
| Weighted Average Shares Outstanding (Diluted) | 147.55 Million | 1.47 Billion | 1.46 Billion | 1.45 Billion | 1.44 Billion | 1.44 Billion |
| Gross Margin | 0.57 | 0.56 | 0.58 | 0.58 | 0.59 | 0.57 |
| EBIT Margin | 0.33 | 0.32 | 0.35 | 0.33 | 0.32 | 0.30 |
| Profit Margin | 0.22 | 0.21 | 0.15 | 0.16 | 0.16 | 0.16 |
| EBITDA | 1.52 Billion | 1.34 Billion | 1.17 Billion | 1.1 Billion | 922.89 Million | 775.81 Million |
| Earnings Before Tax Margin | 0.28 | 0.27 | 0.28 | 0.27 | 0.22 | 0.22 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 1.22 Billion | 4.68 Billion | 1.19 Billion | 1.16 Billion | 950.29 Million | 4.22 Billion |
| Cost of Revenue | 499.68 Million | 1.99 Billion | 504.19 Million | 515.86 Million | 409.48 Million | 1.86 Billion |
| Gross Profit | 723.51 Million | 2.68 Billion | 692.78 Million | 646.93 Million | 540.81 Million | 2.35 Billion |
| Operating Expenses | 359.86 Million | 1.37 Billion | 318.19 Million | 307.61 Million | 265.07 Million | 1.2 Billion |
| Selling, General and Administrative Expenses | 242.18 Million | - | 229.91 Million | 222.15 Million | 193.93 Million | - |
| Research and Development Expenses | 80.86 Million | - | 77.07 Million | 73.88 Million | 63.18 Million | - |
| Other Expenses | -2.95 Million | - | -2.49 Million | -686 Thousand | -1.5 Million | -5.71 Million |
| Cost and Expenses | 859.54 Million | 3.37 Billion | 822.39 Million | 823.47 Million | 674.55 Million | 3.07 Billion |
| Operating Income | 381.21 Million | 1.38 Billion | 374.58 Million | 275.09 Million | 275.73 Million | 1.13 Billion |
| Interest Expense | - | - | - | - | - | 47.37 Million |
| Income Tax Expense | 65.49 Million | 243.84 Million | 74.92 Million | 50.65 Million | 51.31 Million | 204.1 Million |
| Earnings before Tax | 357.73 Million | 1.26 Billion | 375.42 Million | 259.45 Million | 261.79 Million | 1.1 Billion |
| Net Income | 292.23 Million | 1.02 Billion | 300.49 Million | 208.8 Million | 219.42 Million | 897.55 Million |
| Earnings Per Share Basic | 0.20 | - | 0.20 | 0.14 | 0.14 | - |
| Earnings Per Share Diluted | 0.20 | - | 0.20 | 0.14 | 0.14 | - |
| Weighted Average Shares Outstanding | 1.46 Billion | 1.47 Billion | 1.46 Billion | 1.47 Billion | 1.47 Billion | 1.46 Billion |
| Weighted Average Shares Outstanding (Diluted) | 1.47 Billion | 1.47 Billion | 1.47 Billion | 1.47 Billion | 1.47 Billion | 1.47 Billion |
| Gross Margin | 0.59 | 0.57 | 0.58 | 0.56 | 0.57 | 0.56 |
| EBIT Margin | 0.35 | - | 0.36 | 0.39 | 0.34 | - |
| Profit Margin | 0.24 | 0.22 | 0.25 | 0.18 | 0.23 | 0.21 |
| EBITDA | 424.89 Million | - | 429.22 Million | 456.92 Million | 319.77 Million | - |
| Earnings Before Tax Margin | 0.31 | 0.30 | 0.31 | 0.24 | 0.29 | 0.27 |
CTRA
TOM
SLMNP
KNSL
AOJ-B
AOUT